CRISPR Methods for Treating Microbial Infections - SNIPR Biome
Summary
SNIPR Biome ApS filed USPTO patent application US20260098260A1 covering CRISPR-based methods for treating microbial infections including sepsis, septicemia, SIRS, and septic shock. The application also covers controlling microbiologically influenced corrosion and biofouling in industrial or domestic systems using CRISPR technology. Inventors include Morten Sommer, Virginia Martinez, Eric van der Helm, Jakob Krause Haaber, Ana de Santiago Torio, Christian Grøndahl, and Jasper Clube.
What changed
USPTO published patent application US20260098260A1 filed by SNIPR Biome ApS covering CRISPR methods for treating microbial infections. The application specifically addresses treatment of acute conditions such as septicemia, sepsis, SIRS, and septic shock, as well as infections in immunocompromised patients receiving transplants, cancer treatments, or autoimmune disease treatments. The application also covers CRISPR uses for controlling microbiologically influenced corrosion and biofouling.
Patent applications do not create compliance obligations. Interested parties including pharmaceutical and biotechnology companies developing CRISPR-based therapeutics should monitor this application's prosecution for potential freedom-to-operate considerations. Researchers in antimicrobial and industrial biotechnology fields may find this application's claims relevant to their development activities.
What to do next
- Monitor for updates
Archived snapshot
Apr 11, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
TREATING AND PREVENTING MICROBIAL INFECTIONS
Application US20260098260A1 Kind: A1 Apr 09, 2026
Assignee
SNIPR Biome ApS
Inventors
Morten SOMMER, Virginia MARTINEZ, Eric VAN DER HELM, Jakob Krause HAABER, Ana DE SANTIAGO TORIO, Christian GRØNDAHL, Jasper CLUBE
Abstract
The invention provides methods for treating or preventing microbial (eg, bacterial) infections and means for performing these methods. In particular, treatment of infections requiring rapid and durable therapy is made possible, such as for treating acute conditions such as septicemia, sepsis, SIRS or septic shock. The invention is particularly useful, for example, for treatment of microbes such as for environmental, food and beverage use. The invention relates inter alia to methods of controlling microbiologically influenced corrosion (MIC) or biofouling of a substrate or fluid in an industrial or domestic system. The invention also useful for the treatment of pathogenic bacterial infections in subjects receiving a treatment for a disease or condition, such as a transplant or a treatment for cancer, a viral infection or an autoimmune disease.
CPC Classifications
C12N 15/11 A61K 38/465 A61K 39/3955 A61K 39/39558 A61P 31/04 C07K 16/2818 C07K 16/2827 C12N 2310/20 C12N 2320/30 C12N 2320/31 Y02A 50/30
Filing Date
2025-10-23
Application No.
19367030
Related changes
Get daily alerts for USPTO Patent Applications - Peptides (C07K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Peptides (C07K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.